We identified a microtubule-associated serine/threonine kinase 1 (MAST1) as a common essential driver for cisplatin resistance that provides a post-target cisplatin resistance mechanism through managing the pro-apoptotic pathway in human cancers, including lung, ovarian, and head and neck cancers33. The gene discussed is MAST1; the disease is cancer.